Analyzes 20-HETE's role in reducing lung damage from Nickel nanoparticles, suggesting therapeutic potential.
Nickel nanoparticles (Nano-Ni) are widely utilized in industrial and biomedical applications due to their unique physicochemical properties. However, their expanded usage increases risks of occupational and environmental exposure. In this study, we established a mouse exposure model via single intratracheal instillation of Nano-Ni and analyzed the perturbation characteristics of lung tissue metabolic profiles using untargeted metabolomics. Subsequently, the biological function of the key metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) was explored in Nano-Ni-exposed lung epithelial cells to elucidate the underlying mechanisms of metabolic alterations in Nano-Ni-induced pulmonary fibrosis. Our results showed that exposure to Nano-Ni induced marked alveolar architecture destruction, interstitial thickening, and upregulated expression of fibrotic markers in mouse lung tissues. Metabolomics identified arachidonic acid metabolism as the most disrupted pathway, with 20-HETE exhibiting the most pronounced downregulation. In both BEAS-2B and A549 cell lines, exogenous 20-HETE supplementation significantly attenuated Nano-Ni-induced epithelial-mesenchymal transition (EMT). Furthermore, Nano-Ni exposure reduced mRNA and protein levels of free fatty acid receptor 1 (FFAR1) both in vivo and in vitro. Pretreatment with the FFAR1 agonist GW9508 mitigated Nano-Ni-induced EMT and the activation of NF-κB signaling pathway in both cell lines. Critically, FFAR1 inhibition largely abolished the suppressive effects of 20-HETE on EMT and NF-κB signaling. Altogether, our study suggests that 20-HETE may affect the EMT process in lung epithelial cells at least in part through regulating the FFAR1/NF-κB pathway, thereby potentially contributing to the process of Nano-Ni-induced lung fibrosis. These findings point to a possible role of specific metabolites in Nano-Ni-induced pulmonary fibrosis and may provide novel mechanistic insights into the inhalation toxicity of nanomaterials.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: